SCHEMBL2904936

SCHEMBL2904936

NC(=O)c1cc2ccccc2nc1N[C@@H]1CCc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.56
RPS6KB1 P23443 3/20 0.56
AURKB Q96GD4 1/20 0.49
CD38 P28907 2/20 0.47
IKBKB O14920 1/20 0.46
GBA1 P04062 1/20 0.43
GLP1R P43220 1/20 0.43
EGFR P00533 1/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HPGDS O60760 1/20 0.41
CHEK2 O96017 1/20 0.41
FADS1 O60427 1/20 0.41
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
KCNN3 Q9UGI6 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3429529 0.87 AURKA (0.51) AURKARPS6KB1AURKBCD38GBA1
SCHEMBL2905910 0.85 AURKA (0.53) AURKARPS6KB1AURKBCD38GBA1
SCHEMBL4098815 0.82 AURKA (0.46) AURKARPS6KB1AURKBCD38GBA1
SCHEMBL2906297 0.82 AURKA (0.41) AURKARPS6KB1AURKBGBA1GLP1R
SCHEMBL2906202 0.82 GBA1 (0.47) AURKARPS6KB1GBA1GLP1REGFR
SCHEMBL2904940 0.82 GBA1 (0.47) AURKARPS6KB1GBA1GLP1REGFR
SCHEMBL2906027 0.79 GBA1 (0.45) AURKARPS6KB1GBA1GLP1REGFR
SCHEMBL2905882 0.77 PRKCQ (0.48) AURKARPS6KB1GBA1GLP1REGFR
SCHEMBL2905886 0.77 PRKCQ (0.48) AURKARPS6KB1GBA1GLP1REGFR
SCHEMBL2905955 0.76 GBA1 (0.45) AURKARPS6KB1GBA1GLP1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US claimed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US claimed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A AURKA 1160/4885RPS6KB1 1064/4885AURKB 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.